Mirum Pharmaceuticals MIRM
NASDAQ MIRM
$94.61 +0.19 (+0.20%)
At close: Nov 11, 2026 · 4:00 PM EST

Mirum Pharmaceuticals (MIRM) Change in Accrued Expenses (2019 - 2026)

Updated

Mirum Pharmaceuticals' Change in Accrued Expenses came in at $29.19 million for Q3 2026, up 19.9% from $24.35 million a year earlier.

Analysis

Mirum Pharmaceuticals (MIRM) Change in Accrued Expenses (2019 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, Mirum Pharmaceuticals reported Change in Accrued Expenses of $70.82 million, up 26.5% year-over-year; for FY2025, it came in at $50.1 million, up 24.3% from FY2024.

  • Change in Accrued Expenses has increased in each of the last three years, with a five-year compound annual growth rate of 68.6% (FY2020 to FY2025).
  • Going back by year, Change in Accrued Expenses was $40.31 million in FY2024 (+31.0%), $30.78 million in FY2023 (+302.9%), $7.64 million in FY2022 (-66.3%) and $22.66 million in FY2021 (+515.1%).
  • The five-year range for quarterly Change in Accrued Expenses is -$19.06 million (Q2 2026) to $57.24 million (Q1 2026).
  • Year-over-year, Change in Accrued Expenses increased in five of the last seven quarters, with growth averaging 66.6%.
  • The fastest year-over-year change in Change in Accrued Expenses over five years came in Q1 2026 (growth of 387.7%), and the weakest in Q4 2025 (a decline of 63.1%).
  • Business Quant data shows MIRM's Change in Accrued Expenses at -$19.06 million (Q2 2026), $57.24 million (Q1 2026) and $3.44 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accrued Exp. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.41 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 983.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -87.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 756.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Mirum Pharmaceuticals 6.16 Bn 4.58 Bn 150.55 Mn 29.19 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 29.19 Mn
Jun 30, 2026 -19.06 Mn
Mar 31, 2026 57.24 Mn
Dec 31, 2025 3.44 Mn
Sep 30, 2025 24.35 Mn
Jun 30, 2025 10.58 Mn
Mar 31, 2025 11.74 Mn
Dec 31, 2024 9.34 Mn
Sep 30, 2024 12.75 Mn
Jun 30, 2024 6.94 Mn
Mar 31, 2024 11.28 Mn
Dec 31, 2023 12.53 Mn
Sep 30, 2023 10.29 Mn
Jun 30, 2023 9.18 Mn
Mar 31, 2023 -1.21 Mn
Dec 31, 2022 -5,000.00
Sep 30, 2022 6.83 Mn
Jun 30, 2022 8.89 Mn
Mar 31, 2022 -8.07 Mn
Dec 31, 2021 9.02 Mn
API Access

Mirum Pharmaceuticals Change in Accrued Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=MIRM&period=max&api_key=YOUR_API_KEY